Table 2. Clinical characteristics of lung cancers associated with improved outcomes after consolidative localized therapy to metastatic sites.

Patients with ≤3 metastatic sites (18)

No lymph nodes involvement (19,20)

Patients with no bone metastatic disease (20)

Non-squamous histology (19)

Metachronous disease (19)

Smaller primary tumor (20)

Age <60 years (20)